80 likes | 82 Views
Hemophilia is a hereditary genetic blood disorder that affects the capacity of the blood to clot due to the lack of a particular protein needed for blood clotting. The hemophilia is graded as Hemophilia A, Hemophilia B, and C. Many recombinant drugs, such as an antihemophilic factor or Factor VII, are injectable.<br><br>Read More:- https://www.theinsightpartners.com/reports/hemophilia-treatment-market
E N D
Hemophilia Treatment Market Global Analysis and Forecast to 2027 Published Date : Feb 2020 Email: sales@theinsightpartners.com
Email:sales@theinsightpartners.com Report Studies • Hemophilia Treatment Market to 2027 - Global Analysis and Forecasts by Product (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic Agents); Disease (Hemophilia A, Hemophilia B, Hemophilia C); Treatment Type (On-demand, Prophylaxis); Therapy (Replacement Therapy, ITI Therapy, Gene Therapy, Antibody Therapy); End User (Hospitals, Clinics, Ambulatory Surgical Centres, Others), and Geography
Email:sales@theinsightpartners.com Hemophilia Treatment Market Value CAGR of 6.1% (2020 to 2027)
Email:sales@theinsightpartners.com Hemophilia Treatment Market Overview • The Hemophilia Treatment Market was valued at US$ 12,797.36 million in 2019 and it is projected to reach US$ 20,507.92 million in 2027; it is expected to grow at a CAGR of 6.1% from 2020 to 2027. • Hemophilia is a hereditary genetic blood disorder that affects the capacity of the blood to clot due to the lack of a particular protein needed for blood clotting.
Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • Product (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic Agents) • Disease (Hemophilia A, Hemophilia B, Hemophilia C) • Treatment Type (On-demand, Prophylaxis) • Therapy (Replacement Therapy, ITI Therapy, Gene Therapy, Antibody Therapy) • End User (Hospitals, Clinics, Ambulatory Surgical Centres, Others)
Email:sales@theinsightpartners.com Company Profiles • Bayer AG • Sanofi • F. Hoffmann-la Roche Ltd. • Kedrion S.P.A. • CSL Limited • Biotest AG • Pfizer Inc. • Novo Nordisk A/S • Octapharma AG • Baxter International Inc. Download Sample Here
Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).
THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com